Related Experiment Video
Updated: Jul 19, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Detection breadth and limits for potential adventitious/endogenous contaminants in biopharmaceutical processes: a
1Merck Research Laboratories, West Point, PA 19486-0004, USA. paul_duncan@merck.com
Abstract:
In this presentation we address the "gold standards" among diagnostic tests used to detect some potential adventitious and endogenous contaminants in human biologics and vaccines, reflecting on the breadth as well as limits of detection of these assays. This perspective may help developers of innovative diagnostics to address the unique needs of this highly regulated industry.
Related Concept Videos
Upstream Processing
Rapid Identification of Pathogens
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
iChip
Drug Products: Biologics, Biosimilars and Interchangeables
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
